72 related articles for article (PubMed ID: 11910848)
1. Too much vitamin A raises hip-fracture risk, except in women taking HRT.
Health News; 2002 Mar; 8(3):6. PubMed ID: 11910848
[No Abstract] [Full Text] [Related]
2. By the way doctor. In your March issue, you reported that excess vitamin A is a possible cause of hip fracture. I'm trying to lower my intake and have searched in vain for a multiple vitamin with the new recommended dietary allowance. What do you recommend?
Harv Womens Health Watch; 2002 Oct; 10(2):8. PubMed ID: 12393321
[No Abstract] [Full Text] [Related]
3. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES
Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403
[TBL] [Abstract][Full Text] [Related]
4. I've read that too much vitamin A can weaken bones. How much is too much?
Mayo Clin Health Lett; 2011 Dec; 29(12):8. PubMed ID: 22295301
[No Abstract] [Full Text] [Related]
5. Vitamin A intake and osteoporosis: a clinical review.
Crandall C
J Womens Health (Larchmt); 2004 Oct; 13(8):939-53. PubMed ID: 15671709
[TBL] [Abstract][Full Text] [Related]
6. The retinol (vitamin A) risk. Does too much vitamin A increase fracture risk? The evidence is piling up.
Harv Womens Health Watch; 2003 Apr; 10(8):1. PubMed ID: 12711556
[No Abstract] [Full Text] [Related]
7. Osteoporosis a disease for all; in Lebanon.
Ghassan M; Alexandre N; Joseph W; Fadi H; Georges F; Joseph H; Marie Hélène GY
Clin Calcium; 2004 Sep; 14(9):116-22. PubMed ID: 15577123
[TBL] [Abstract][Full Text] [Related]
8. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
Shintani M
Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
[TBL] [Abstract][Full Text] [Related]
9. Does excess vitamin A cause hip fracture?
Harv Womens Health Watch; 2002 Mar; 9(7):1-3. PubMed ID: 11916653
[No Abstract] [Full Text] [Related]
10. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
[TBL] [Abstract][Full Text] [Related]
11. [Absolute risk for fracture and WHO guideline. Fracture risk assessment based on femoral neck bone mineral density : advantage and disadvantage].
Sone T;
Clin Calcium; 2007 Jul; 17(7):1036-40. PubMed ID: 17607070
[TBL] [Abstract][Full Text] [Related]
12. Clinical management of osteoporosis in Singapore.
Hong LK
Clin Calcium; 2004 Sep; 14(9):112-5. PubMed ID: 15577122
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
[TBL] [Abstract][Full Text] [Related]
14. Serum vitamin A concentration and the risk of hip fracture among women 50 to 74 years old in the United States: a prospective analysis of the NHANES I follow-up study.
Opotowsky AR; Bilezikian JP;
Am J Med; 2004 Aug; 117(3):169-74. PubMed ID: 15276595
[TBL] [Abstract][Full Text] [Related]
15. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hip fractures: medical and nonmedical management.
Lin JT; Lane JM
Instr Course Lect; 2004; 53():417-25. PubMed ID: 15116631
[TBL] [Abstract][Full Text] [Related]
18. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
Seeman E; Eisman JA
Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
[TBL] [Abstract][Full Text] [Related]
19. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
20. Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.
Suzuki Y; Whiting SJ; Davison KS; Chilibeck PD
J Nutr Health Aging; 2003; 7(5):296-9. PubMed ID: 12917743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
